Navigation Links
Wyeth Declares Common and Preferred Stock Dividends
Date:4/23/2009

MADISON, N.J., April 23 /PRNewswire-FirstCall/ -- At a meeting of its Board of Directors, held today, Wyeth (NYSE: WYE) declared dividends on both the Common and Preferred Stock of the Company.

A dividend of thirty cents ($.30) per share on the outstanding shares of Common Stock was declared payable on June 1, 2009 to stockholders of record at the close of business on May 13, 2009.

In addition, a dividend of fifty cents ($.50) per share on the outstanding shares of Preferred Stock was declared payable on July 1, 2009 to stockholders of record at the close of business on June 12, 2009.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Wyeth Sets Webcast and Conference Call for 2009 First Quarter Earnings
2. Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference
3. Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
4. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
5. Wyeth Declares Preferred Stock Dividend
6. Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
7. Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
8. Wyeth Announces Increase in Common Stock Dividend
9. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
10. Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
11. Cyprus and Ireland Add Wyeths 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... cellulose nanocrystals and cellulose nanofibrils. The composition claims are not limited to ... claims directed to combination with polymers, carbon fibers, graphene, and other materials. ...
(Date:12/5/2016)... Dec. 5, 2016  Renova™ Therapeutics, a biotechnology ... failure and other chronic diseases, announced that ... as Chief Financial Officer (CFO), effective today. ... years of experience in financial management for a ... software companies. Most recently, Ms. Bovenizer was the ...
(Date:12/5/2016)... The U.S. Biotechnology industry is ... of revenue and some $890 billion of total market ... biopharmaceuticals, and this figure is expected to exceed $220 ... these four equities for assessment: Northwest Biotherapeutics Inc. (NASDAQ: ... ACAD ), Acorda Therapeutics Inc. (NASDAQ: ...
(Date:12/2/2016)... ... December 02, 2016 , ... In anticipation of ... lumbar disc production, company President, Jake Lubinski will be traveling to Switzerland from ... disc in Bern, Lucerne, and Zurich to discuss the benefits of a viscoelastic ...
Breaking Biology Technology:
(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. ... has priced an offering of €500.0 million principal amount of ... principal amount of its 2.425% senior unsecured notes due 2026. ... to occur on December 13, 2016, subject to the satisfaction of ... annual basis. The Company intends ...
(Date:12/6/2016)... , Dec. 6, 2016 Valencell , the ... it has seen a third consecutive year of triple ... technology in 2016 with a 360 percent increase in ... This increase was driven by sales of its wrist ... interest in its technology for hearables for fitness and ...
(Date:12/6/2016)... Dec. 6, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... today a five (5) year funding commitment by ... expand the rehabilitation and reentry support to more ... Established in 2004, the Prison Entrepreneurship Program (PEP) ...
Breaking Biology News(10 mins):